So what if I told you that everything you think you know about cancer is about to change and maybe already has?

That we're living through a moment where our understanding and ability to treat this collection of diseases is transforming at a pace that would have seemed impossible just years ago.

I mean, picture a future where we can identify

and intercept cancer potentially even before it becomes cancer, where treatments are tailored

to your specific molecular profile, where AI helps doctors make better decisions faster.

That's what we're talking about in today's sixth installment in our Future of Medicine series. My guest is

Dr. Ross Levine, Chief Scientific Officer at Memorial Sloan Kettering Cancer Center, one of the

world's premier cancer research and treatment institutions. As a physician researcher, his lab focuses

on understanding the genetic basis of blood cancers, and his work has earned him

countless accolades. In our conversation, we explore why cancer isn't actually one disease,

but hundreds of distinct conditions, and how this understanding is revolutionizing treatment.

You'll learn about fascinating advances in immunotherapy that are already changing lives,

new diagnostic tests and approaches,

and treatment protocols that are changing the face of how we understand, treat, and even eliminate

cancer. You'll hear stories that will fill you with hope about where medicine is headed,

and wait until you hear what Dr. Levine reveals about the role artificial intelligence is playing

in cancer diagnosis and treatment.

It is transforming everything.

So excited to share this conversation with you.

I'm Jonathan Fields, and this is Good Life Project.

As we have this conversation, I want to say six of the most terrifying letters in the English language strung together into a single word cancer.

Is something that people, we all know it.

...